These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25090991)

  • 21. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
    Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
    Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
    Bostrom MA; Kao WH; Li M; Abboud HE; Adler SG; Iyengar SK; Kimmel PL; Hanson RL; Nicholas SB; Rasooly RS; Sedor JR; Coresh J; Kohn OF; Leehey DJ; Thornley-Brown D; Bottinger EP; Lipkowitz MS; Meoni LA; Klag MJ; Lu L; Hicks PJ; Langefeld CD; Parekh RS; Bowden DW; Freedman BI;
    Am J Kidney Dis; 2012 Feb; 59(2):210-21. PubMed ID: 22119407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
    Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
    J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.
    Hoy WE; Hughson MD; Kopp JB; Mott SA; Bertram JF; Winkler CA
    J Am Soc Nephrol; 2015 Dec; 26(12):3179-89. PubMed ID: 26038529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
    Bentley AR; Divers J; Shriner D; Doumatey AP; Gutiérrez OM; Adeyemo AA; Freedman BI; Rotimi CN
    BMC Genomics; 2015 May; 16(1):421. PubMed ID: 26025194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOL1 Variants: From Parasites to Kidney Function to Cardiovascular Disease.
    Reiner AP; Susztak K
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):219-20. PubMed ID: 26819463
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
    Riella LV; Sheridan AM
    Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population genetics of chronic kidney disease: the evolving story of APOL1.
    Wasser WG; Tzur S; Wolday D; Adu D; Baumstein D; Rosset S; Skorecki K
    J Nephrol; 2012; 25(5):603-18. PubMed ID: 22878977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
    Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
    Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOL1 variants associate with increased risk of CKD among African Americans.
    Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
    J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of circulating APOL1 protein complexes in African Americans.
    Weckerle A; Snipes JA; Cheng D; Gebre AK; Reisz JA; Murea M; Shelness GS; Hawkins GA; Furdui CM; Freedman BI; Parks JS; Ma L
    J Lipid Res; 2016 Jan; 57(1):120-30. PubMed ID: 26586272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
    Langefeld CD; Divers J; Pajewski NM; Hawfield AT; Reboussin DM; Bild DE; Kaysen GA; Kimmel PL; Raj DS; Ricardo AC; Wright JT; Sedor JR; Rocco MV; Freedman BI;
    Kidney Int; 2015 Jan; 87(1):169-75. PubMed ID: 25029429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein L1: from obscurity to consistency to controversy.
    Lipkowitz MS
    Kidney Int; 2015 Jan; 87(1):14-7. PubMed ID: 25549121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
    Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
    Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
    Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
    Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
    Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.